capadenoson   Click here for help

GtoPdb Ligand ID: 11221

Synonyms: BAY 68-4986 | BAY-68-4986 | BAY684986
Compound class: Synthetic organic
Comment: Capadenoson is an investigational, selective partial agonist of adenosine A1 receptor [1]. Its pharmacokinetics support oral once daily administration.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 182.38
Molecular weight 519.06
XLogP 4.64
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N
Isomeric SMILES OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N
InChI InChI=1S/C25H18ClN5O2S2/c26-17-5-1-16(2-6-17)24-30-18(13-34-24)14-35-25-21(12-28)22(20(11-27)23(29)31-25)15-3-7-19(8-4-15)33-10-9-32/h1-8,13,32H,9-10,14H2,(H2,29,31)
InChI Key CITWCLNVRIKQAF-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Capadenoson was progressed to clinical evaluation as a treatment for angina pectoris or persistent or permanent atrial fibrillation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00518921 Capadenoson in Angina Pectoris Phase 2 Interventional Bayer This trial was withdrawn for undisclosed reasons.
NCT00568945 Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation. Phase 2 Interventional Bayer